Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 8 | 2024 | 447 | 2.150 |
Why?
|
| Health Care Costs | 6 | 2019 | 192 | 1.460 |
Why?
|
| Health Knowledge, Attitudes, Practice | 7 | 2019 | 352 | 1.440 |
Why?
|
| Genetic Testing | 4 | 2024 | 63 | 1.420 |
Why?
|
| Early Detection of Cancer | 7 | 2023 | 553 | 1.360 |
Why?
|
| Skin Neoplasms | 3 | 2023 | 59 | 1.340 |
Why?
|
| Communication | 6 | 2021 | 183 | 1.320 |
Why?
|
| Physician-Patient Relations | 3 | 2019 | 169 | 1.290 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2020 | 353 | 1.200 |
Why?
|
| Humans | 49 | 2024 | 16832 | 1.190 |
Why?
|
| Health Expenditures | 4 | 2020 | 69 | 1.090 |
Why?
|
| Family | 3 | 2024 | 99 | 1.080 |
Why?
|
| Vaccination | 6 | 2022 | 725 | 1.080 |
Why?
|
| Genomics | 3 | 2021 | 54 | 1.070 |
Why?
|
| Medical Oncology | 4 | 2016 | 34 | 1.040 |
Why?
|
| Parents | 7 | 2020 | 298 | 0.970 |
Why?
|
| Mass Screening | 7 | 2023 | 670 | 0.920 |
Why?
|
| Psychometrics | 2 | 2019 | 114 | 0.900 |
Why?
|
| Melanoma | 2 | 2023 | 35 | 0.870 |
Why?
|
| Vaccines | 5 | 2022 | 225 | 0.850 |
Why?
|
| Patient Preference | 2 | 2017 | 46 | 0.800 |
Why?
|
| Professional-Family Relations | 3 | 2020 | 52 | 0.710 |
Why?
|
| Adult | 17 | 2024 | 7255 | 0.670 |
Why?
|
| Leadership | 2 | 2020 | 34 | 0.670 |
Why?
|
| Duty to Recontact | 1 | 2021 | 2 | 0.670 |
Why?
|
| Physicians | 3 | 2020 | 114 | 0.660 |
Why?
|
| Washington | 6 | 2021 | 376 | 0.660 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 18 | 0.660 |
Why?
|
| Genetic Research | 2 | 2019 | 7 | 0.660 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2024 | 319 | 0.650 |
Why?
|
| Behavioral Medicine | 1 | 2020 | 4 | 0.650 |
Why?
|
| Cancer Survivors | 2 | 2020 | 114 | 0.590 |
Why?
|
| Ethics Committees, Research | 1 | 2019 | 8 | 0.590 |
Why?
|
| Workflow | 1 | 2019 | 11 | 0.590 |
Why?
|
| Policy | 1 | 2019 | 19 | 0.590 |
Why?
|
| Social Determinants of Health | 1 | 2019 | 39 | 0.580 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 76 | 0.580 |
Why?
|
| Health Communication | 2 | 2017 | 16 | 0.570 |
Why?
|
| Risk Assessment | 4 | 2019 | 1047 | 0.570 |
Why?
|
| Decision Making | 2 | 2011 | 164 | 0.560 |
Why?
|
| Health Behavior | 2 | 2018 | 332 | 0.560 |
Why?
|
| Colorectal Neoplasms | 4 | 2021 | 635 | 0.550 |
Why?
|
| Patient Selection | 4 | 2011 | 175 | 0.550 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 196 | 0.550 |
Why?
|
| Primary Health Care | 3 | 2023 | 693 | 0.550 |
Why?
|
| Sunburn | 1 | 2018 | 3 | 0.550 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 60 | 0.540 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 160 | 0.540 |
Why?
|
| Adolescent | 10 | 2023 | 3464 | 0.520 |
Why?
|
| Ambulatory Care | 1 | 2019 | 205 | 0.520 |
Why?
|
| Papillomavirus Vaccines | 2 | 2017 | 113 | 0.520 |
Why?
|
| Papillomavirus Infections | 2 | 2017 | 141 | 0.510 |
Why?
|
| Insurance Coverage | 2 | 2019 | 102 | 0.500 |
Why?
|
| Point-of-Care Systems | 1 | 2016 | 7 | 0.490 |
Why?
|
| Cancer Care Facilities | 1 | 2016 | 5 | 0.490 |
Why?
|
| Counseling | 1 | 2018 | 170 | 0.490 |
Why?
|
| Surveys and Questionnaires | 7 | 2021 | 1204 | 0.480 |
Why?
|
| Female | 18 | 2024 | 12193 | 0.480 |
Why?
|
| Mothers | 1 | 2017 | 104 | 0.480 |
Why?
|
| Male | 17 | 2024 | 9556 | 0.470 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 58 | 0.470 |
Why?
|
| Disclosure | 1 | 2016 | 15 | 0.470 |
Why?
|
| Evidence-Based Medicine | 3 | 2016 | 160 | 0.430 |
Why?
|
| Value-Based Purchasing | 1 | 2014 | 3 | 0.420 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2014 | 16 | 0.420 |
Why?
|
| Middle Aged | 11 | 2024 | 7515 | 0.400 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 197 | 0.400 |
Why?
|
| Genetic Counseling | 2 | 2024 | 26 | 0.390 |
Why?
|
| Aged | 9 | 2024 | 5901 | 0.370 |
Why?
|
| United States | 9 | 2023 | 3858 | 0.360 |
Why?
|
| Neptune | 1 | 2021 | 1 | 0.350 |
Why?
|
| Quality of Life | 4 | 2022 | 477 | 0.340 |
Why?
|
| Advisory Committees | 3 | 2016 | 112 | 0.340 |
Why?
|
| Risk Factors | 6 | 2020 | 3108 | 0.330 |
Why?
|
| Patient Education as Topic | 2 | 2009 | 186 | 0.320 |
Why?
|
| Cost of Illness | 2 | 2020 | 90 | 0.300 |
Why?
|
| Uncertainty | 1 | 2009 | 4 | 0.300 |
Why?
|
| Vaccination Refusal | 2 | 2019 | 10 | 0.290 |
Why?
|
| Physicians, Primary Care | 2 | 2021 | 63 | 0.280 |
Why?
|
| Qualitative Research | 2 | 2020 | 288 | 0.280 |
Why?
|
| Colonoscopy | 2 | 2021 | 261 | 0.260 |
Why?
|
| Pharmacogenetics | 1 | 2007 | 13 | 0.260 |
Why?
|
| Incidental Findings | 1 | 2007 | 25 | 0.260 |
Why?
|
| Preventive Health Services | 3 | 2016 | 142 | 0.240 |
Why?
|
| Registries | 2 | 2014 | 449 | 0.240 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 346 | 0.240 |
Why?
|
| Health Policy | 1 | 2007 | 101 | 0.240 |
Why?
|
| Treatment Outcome | 4 | 2022 | 1098 | 0.240 |
Why?
|
| Interviews as Topic | 3 | 2019 | 305 | 0.230 |
Why?
|
| Referral and Consultation | 1 | 2007 | 147 | 0.230 |
Why?
|
| Physical Examination | 2 | 2023 | 20 | 0.220 |
Why?
|
| Minority Groups | 2 | 2020 | 99 | 0.220 |
Why?
|
| Exercise Therapy | 2 | 2018 | 71 | 0.210 |
Why?
|
| Young Adult | 5 | 2019 | 2456 | 0.200 |
Why?
|
| Sensitivity and Specificity | 3 | 2019 | 291 | 0.200 |
Why?
|
| Pilot Projects | 2 | 2016 | 210 | 0.190 |
Why?
|
| Veterans Health | 1 | 2023 | 16 | 0.190 |
Why?
|
| Infant | 5 | 2020 | 1212 | 0.190 |
Why?
|
| Prevalence | 2 | 2015 | 785 | 0.190 |
Why?
|
| Attitude to Health | 2 | 2018 | 142 | 0.180 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 1233 | 0.180 |
Why?
|
| Burnout, Professional | 1 | 2021 | 11 | 0.170 |
Why?
|
| Smartphone | 1 | 2021 | 10 | 0.170 |
Why?
|
| Models, Economic | 1 | 2020 | 16 | 0.160 |
Why?
|
| Research Personnel | 1 | 2020 | 24 | 0.160 |
Why?
|
| Child | 5 | 2018 | 2433 | 0.160 |
Why?
|
| Medical Overuse | 1 | 2020 | 14 | 0.150 |
Why?
|
| Telephone | 1 | 2021 | 157 | 0.150 |
Why?
|
| Occult Blood | 1 | 2021 | 161 | 0.150 |
Why?
|
| Pancreas | 1 | 2019 | 14 | 0.150 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 23 | 0.150 |
Why?
|
| Infant, Newborn | 3 | 2019 | 828 | 0.150 |
Why?
|
| Consumer Behavior | 1 | 2019 | 27 | 0.150 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 73 | 0.140 |
Why?
|
| Postoperative Complications | 1 | 2019 | 103 | 0.140 |
Why?
|
| Self-Examination | 1 | 2018 | 2 | 0.140 |
Why?
|
| Sunscreening Agents | 1 | 2018 | 5 | 0.140 |
Why?
|
| Skin Pigmentation | 1 | 2018 | 6 | 0.140 |
Why?
|
| Braces | 1 | 2018 | 2 | 0.140 |
Why?
|
| Scoliosis | 1 | 2018 | 3 | 0.130 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 45 | 0.130 |
Why?
|
| Preventive Medicine | 1 | 2018 | 21 | 0.130 |
Why?
|
| Medical History Taking | 1 | 2017 | 30 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 374 | 0.130 |
Why?
|
| Ethnic Groups | 1 | 2020 | 418 | 0.130 |
Why?
|
| Social Work | 1 | 1997 | 15 | 0.120 |
Why?
|
| Physician's Role | 1 | 2017 | 25 | 0.120 |
Why?
|
| Homeless Persons | 1 | 1997 | 23 | 0.120 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 21 | 0.120 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2016 | 2 | 0.120 |
Why?
|
| Housing | 1 | 1997 | 38 | 0.120 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2016 | 23 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 55 | 0.120 |
Why?
|
| Dyslipidemias | 1 | 2016 | 57 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 1887 | 0.110 |
Why?
|
| Choice Behavior | 1 | 2015 | 44 | 0.110 |
Why?
|
| Perception | 1 | 2015 | 53 | 0.110 |
Why?
|
| Family Health | 1 | 2015 | 40 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1058 | 0.100 |
Why?
|
| Northwestern United States | 1 | 2014 | 53 | 0.100 |
Why?
|
| Health Information Systems | 1 | 2014 | 3 | 0.100 |
Why?
|
| Mass Vaccination | 1 | 2014 | 22 | 0.100 |
Why?
|
| Hospitalization | 1 | 2019 | 816 | 0.100 |
Why?
|
| Data Collection | 1 | 2014 | 223 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 489 | 0.090 |
Why?
|
| Internet | 1 | 2014 | 207 | 0.090 |
Why?
|
| Age Factors | 3 | 2021 | 814 | 0.090 |
Why?
|
| Manipulation, Spinal | 1 | 2011 | 3 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 5 | 0.090 |
Why?
|
| Software | 1 | 2021 | 18 | 0.090 |
Why?
|
| Acupuncture Therapy | 1 | 2011 | 34 | 0.080 |
Why?
|
| Low Back Pain | 1 | 2011 | 59 | 0.080 |
Why?
|
| Interview, Psychological | 1 | 2011 | 14 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 311 | 0.080 |
Why?
|
| Time Factors | 2 | 2011 | 989 | 0.080 |
Why?
|
| Chronic Pain | 1 | 2011 | 125 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 317 | 0.070 |
Why?
|
| Focus Groups | 1 | 2009 | 140 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2014 | 515 | 0.070 |
Why?
|
| Patient-Centered Care | 2 | 2023 | 185 | 0.070 |
Why?
|
| Patient Participation | 1 | 2009 | 120 | 0.070 |
Why?
|
| Pharmacokinetics | 1 | 2007 | 1 | 0.060 |
Why?
|
| Biotransformation | 1 | 2007 | 3 | 0.060 |
Why?
|
| Genetic Privacy | 1 | 2007 | 2 | 0.060 |
Why?
|
| Cholesterol | 2 | 2016 | 75 | 0.060 |
Why?
|
| Electronic Health Records | 1 | 2021 | 702 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2007 | 136 | 0.060 |
Why?
|
| Genetic Services | 1 | 2005 | 1 | 0.060 |
Why?
|
| Cholesterol, LDL | 2 | 2016 | 113 | 0.060 |
Why?
|
| Biomarkers | 2 | 2016 | 284 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 410 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2007 | 995 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2016 | 215 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2007 | 248 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 2 | 2017 | 229 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2020 | 1430 | 0.050 |
Why?
|
| Stroke | 2 | 2016 | 297 | 0.050 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2023 | 113 | 0.050 |
Why?
|
| Patient Outcome Assessment | 1 | 2022 | 26 | 0.040 |
Why?
|
| Patients | 1 | 2022 | 29 | 0.040 |
Why?
|
| Job Satisfaction | 1 | 2021 | 19 | 0.040 |
Why?
|
| Workplace | 1 | 2021 | 34 | 0.040 |
Why?
|
| Workload | 1 | 2021 | 26 | 0.040 |
Why?
|
| Sigmoidoscopy | 1 | 2021 | 61 | 0.040 |
Why?
|
| Mobile Applications | 1 | 2021 | 13 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 453 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2020 | 50 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 203 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2020 | 48 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2019 | 88 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 78 | 0.040 |
Why?
|
| Health Personnel | 1 | 2020 | 132 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 571 | 0.030 |
Why?
|
| Linear Models | 1 | 2018 | 187 | 0.030 |
Why?
|
| Medical Indigency | 1 | 1997 | 4 | 0.030 |
Why?
|
| Social Marketing | 1 | 2017 | 12 | 0.030 |
Why?
|
| Power (Psychology) | 1 | 2016 | 3 | 0.030 |
Why?
|
| Food Services | 1 | 1997 | 15 | 0.030 |
Why?
|
| Massachusetts | 1 | 1997 | 58 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2016 | 16 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 252 | 0.030 |
Why?
|
| Trust | 1 | 2017 | 33 | 0.030 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2016 | 4 | 0.030 |
Why?
|
| Ezetimibe | 1 | 2016 | 4 | 0.030 |
Why?
|
| Dermatology | 1 | 2016 | 7 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 16 | 0.030 |
Why?
|
| Simvastatin | 1 | 2016 | 11 | 0.030 |
Why?
|
| Hypolipidemic Agents | 1 | 2016 | 38 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2016 | 44 | 0.030 |
Why?
|
| Urban Population | 1 | 1997 | 105 | 0.030 |
Why?
|
| Age Distribution | 1 | 2016 | 221 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2023 | 2463 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2016 | 51 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 653 | 0.030 |
Why?
|
| Mental Health Services | 1 | 1997 | 132 | 0.030 |
Why?
|
| Life Style | 1 | 2016 | 305 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 1186 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 155 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2014 | 73 | 0.020 |
Why?
|
| Public Health | 1 | 2014 | 80 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2014 | 294 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 2396 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2011 | 25 | 0.020 |
Why?
|
| Publishing | 1 | 2005 | 9 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 58 | 0.010 |
Why?
|
Concepts
(225)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->